Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the ...
Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System for adults with diabetes.
DexCom DXCM recently announced that the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System has received ...
GlobalData on MSN
Health Canada authorises Dexcom G7 15 Day CGM
The device demonstrates a MARD of 8% and includes a 12-hour grace period and mobile app compatibility.
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, ...
The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...
The FDA has given the green light to Dexcom’s popular over-the-counter glucose monitor Stelo for children two years or older who don’t use insulin. The regulatory agency previously cleared the glucose ...
Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...
Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...
Compare Apple Watch CGM apps for blood sugar readings, including Dexcom G7, FreeStyle Libre, and Eversense watch support.
Compare the best Samsung Watch CGM apps and Wear OS tools for blood sugar readings, including Dexcom G6, Gluroo, and xDrip+.
2don MSN
Influencers are hopping on a surprising wearable trend that requires a needle — do you need one?
Influencers have found their latest wellness obsession — and, once again, diabetics got there first. First, came GLP-1 drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results